The “Supplements, Placebo, or Rosuvastatin (SPORT)” study was presented at the American Heart Association scientific sessions on Nov. 6, 2022 and published in the Journal of the American College of Cardiology. This research measured cholesterol reduction between rosuvastatin (Crestor®) and supplements. One of the author’s conclusions is that doctors should ‘educate’ patients about the lack of benefit supplements have on decreasing the risk of heart attack.
This critical analysis of the SPORT study will rely on published articles by medical experts who offer opinions contrary to the authors. This is intended to stimulate further research before deciding whether to stop and/or refuse a statin prescription.
About the author: Paul Filiatrault is a pharmacist with more than 35 years of clinical and administrative experience in hospital pharmacy settings. He served as Secretary in the Regional Pharmacy & Therapeutics Committee of Interior Health and was Regional Manager of Medication Safety in the development of medication safety-related policies. Being an Accreditation Canada surveyor, Paul also served as a consultant for the Institute for Safe Medication Practices Canada (ISMP Canada). Paul’s passion is teaching people how to optimize their wellness by resolving the many nutrient gaps of the Western diet.